Prognostic Value of Stem Cell Related Markers
NCT01265225 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2013-12-24
Summary
The goal of the investigators study is to identify a prognostic marker that will evaluate the probability of recurrence in patients with stage 0-II breast cancer following surgery to remove the tumor.
Conditions
Sponsors & Collaborators
-
The Baruch Padeh Medical Center, Poriya
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2013-02-28
- Completion
- 2013-04-30
Countries
- Israel
Study Locations
More Related Trials
-
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
NCT01514565 ·Status: UNKNOWN
-
Biomarkers for Breast Cancer Risk in African American Women
NCT01736306 ·Status: COMPLETED
-
Breast Cancer Survivorship Biorepository
NCT05786664 ·Status: RECRUITING
-
Lymph Fluid and Blood Collection for Identification of Novel Biomarkers
NCT01075607 ·Status: TERMINATED
-
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
NCT00897299 ·Status: COMPLETED
-
Predicting Cancer Risk With Digital and Molecular Markers
NCT06962670 ·Status: RECRUITING ·Phase: NA
-
A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT01344109 ·Status: WITHDRAWN
-
Diagnostic Procedures in Detecting Tumor Cells in the Bone Marrow of Patients Undergoing Surgery for Stage I, Stage II, or Stage IIIA Breast Cancer
NCT00089323 ·Status: COMPLETED ·Phase: NA
-
Molecular and Cellular Analysis of Breast Cancer
NCT02243397 ·Status: COMPLETED
-
Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment
NCT05926024 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers in Tissue Samples From Older Women With Breast Cancer
NCT01346579 ·Status: TERMINATED
-
Biomarker Study of Breast Tumors
NCT00941408 ·Status: UNKNOWN
-
BCRL Prevention Pilot
NCT01166672 ·Status: COMPLETED
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065 ·Status: UNKNOWN
-
MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
NCT01649661 ·Status: COMPLETED
-
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
NCT01420185 ·Status: UNKNOWN
-
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 ·Status: UNKNOWN
-
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
NCT00463034 ·Status: UNKNOWN
-
Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy
NCT01568346 ·Status: TERMINATED ·Phase: PHASE3
-
Preoperative Single-Fraction Radiotherapy in Early Stage Breast Cancer
NCT02482376 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Breast Stem Cells in Women at Average Risk and Increased Risk for Breast Cancer
NCT00923377 ·Status: COMPLETED
-
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT01000883 ·Status: RECRUITING
-
RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer
NCT04972448 ·Status: NOT_YET_RECRUITING